Di Clemente F - Search Results

1

Biochemical and immunological responses of hairy cell leukemia patients to interferon beta.

Liberati AM, Horisberger M, Schippa M, Di Clemente F, Fizzotti M, Filippo S, Proietti MG, Arzano S, Berruto P, Palmisano L, et al. Liberati AM, et al. Among authors: di clemente f. Cancer Immunol Immunother. 1991;34(2):115-22. doi: 10.1007/BF01741345. Cancer Immunol Immunother. 1991. PMID: 1760815 Free PMC article.

2

IFN-beta induced biochemical and immunological modifications in hairy cell leukemia patients.

Liberati AM, Schippa M, Portuesi MG, Grazia Proietti M, De Angelis V, Ferrajoli A, Cinieri S, Di Clemente F, Palmisano L, Berruto P. Liberati AM, et al. Among authors: di clemente f. Haematologica. 1991 Sep-Oct;76(5):375-82. Haematologica. 1991. PMID: 1806440

3

Response to intermediate and standard doses of IFN-beta in hairy-cell leukaemia.

Liberati AM, Fizzotti M, Di Clemente F, Senatore M, Berruto P, Falini B, Martelli MF, Grignani F. Liberati AM, et al. Among authors: di clemente f. Leuk Res. 1990;14(9):779-84. doi: 10.1016/0145-2126(90)90071-g. Leuk Res. 1990. PMID: 2232850

4

Natural-killer-stimulatory effect of combined low-dose interleukin-2 and interferon beta in hairy-cell leukemia patients.

Liberati AM, De Angelis V, Fizzotti M, Schippa M, Cecchini M, Adiuto D, Di Clemente F, Palmisano L, Micozzi E, Zuccaccia M, et al. Liberati AM, et al. Among authors: di clemente f. Cancer Immunol Immunother. 1994 May;38(5):323-31. doi: 10.1007/BF01525511. Cancer Immunol Immunother. 1994. PMID: 7512888 Free PMC article.

5

Interferon-alpha-induced biologic modifications in patients with chronic myelogenous leukemia.

Liberati AM, Horisberger MA, Garofani P, De Angelis V, Ferrajoli A, Di Clemente F, Caricchi P, Adiuto D, Fedeli L, Palumbo B. Liberati AM, et al. Among authors: di clemente f. J Interferon Res. 1994 Dec;14(6):349-55. doi: 10.1089/jir.1994.14.349. J Interferon Res. 1994. PMID: 7897254 Clinical Trial.

6

Double-blind randomized phase I study on the clinical tolerance and pharmacodynamics of natural and recombinant interferon-beta given intravenously.

Liberati AM, Garofani P, De Angelis V, Di Clemente F, Horisberger M, Cecchini M, Betti AR, Palmisano L, Astolfi S, Nastari A, et al. Liberati AM, et al. Among authors: di clemente f. J Interferon Res. 1994 Apr;14(2):61-9. doi: 10.1089/jir.1994.14.61. J Interferon Res. 1994. PMID: 8077767 Clinical Trial.

7

GM-CSF: clinical trials in non-Hodgkin's lymphoma patients with chemotherapy induced leucopenia.

Liberati AM, Cinieri S, Schippa M, Di Clemente F, Filippo S, Grignani F. Liberati AM, et al. Among authors: di clemente f. Leukemia. 1991;5 Suppl 1:119-22. Leukemia. 1991. PMID: 1890860 Clinical Trial.

8

Phase I-II trial on natural beta interferon in chemoresistant and relapsing multiple myeloma.

Liberati AM, Cinieri S, Senatore MG, Portuesi MG, De Angelis V, Di Clemente F, Schippa M, Ferrajoli A, Arzano S, Berruto P. Liberati AM, et al. Among authors: di clemente f. Haematologica. 1990 Sep-Oct;75(5):436-42. Haematologica. 1990. PMID: 2129033 Clinical Trial.

9

Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma.

Tovoli F, Dadduzio V, De Lorenzo S, Rimassa L, Masi G, Iavarone M, Marra F, Garajova I, Brizzi MP, Daniele B, Trevisani F, Messina C, Di Clemente F, Pini S, Cabibbo G, Granito A, Rizzato MD, Zagonel V, Brandi G, Pressiani T, Federico P, Vivaldi C, Bergna I, Campani C, Piscaglia F. Tovoli F, et al. Among authors: di clemente f. Liver Cancer. 2021 Jul;10(4):370-379. doi: 10.1159/000515551. Epub 2021 Jun 15. Liver Cancer. 2021. PMID: 34414124 Free PMC article.

10

Exome sequencing in BRCA1-2 candidate familias: the contribution of other cancer susceptibility genes.

Doddato G, Valentino F, Giliberti A, Papa FT, Tita R, Bruno LP, Resciniti S, Fallerini C, Benetti E, Palmieri M, Mencarelli MA, Fabbiani A, Bruttini M, Orrico A, Baldassarri M, Fava F, Lopergolo D, Lo Rizzo C, Lamacchia V, Mannucci S, Pinto AM, Curr A, Mancini V; Oncologic Multidisciplinary Team, Azienda Ospedaliera Universitaria Senese; Oncologic Multidisciplinary Team, Azienda Usl Toscana Sud Est; Mari F, Renieri A, Ariani F. Doddato G, et al. Front Oncol. 2021 May 7;11:649435. doi: 10.3389/fonc.2021.649435. eCollection 2021. Front Oncol. 2021. PMID: 34026625 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters